Restricted accessLetterFirst published online May, 2024

Is MYCN Overexpression Associated With Poor Outcome in MYCN Non-Amplified Neuroblastomas?

and

Volume 27, Issue 3https://doi.org/10.1177/10935266231222321

Abstract

Get full access to this article

View all access options for this article.

References

1.

Zhao

M

Gu

W

Liu

F

, et al. Prominent staining of MYCN immunohistochemistry predicts a poor prognosis in MYCN non-amplified neuroblastoma. Pediatr Dev Pathol. 2023;26(2):124-132.

2.

Yang

Y

Zhao

J

Zhang

Y

, et al. MYCN protein stability is a better prognostic indicator in neuroblastoma. BMC Pediatr. 2022;22(1):404.